Electronic Nudge Letters Fail to Boost Guideline-Adherent Treatment in CKD Patients
A recent study finds that electronic nudge letters do not increase guideline-based medical therapy uptake among CKD patients, highlighting challenges in digital health interventions.
Recent research has shown that sending electronic nudge letters to patients with chronic kidney disease (CKD) or their healthcare providers does not significantly increase the adoption of guideline-recommended medical therapies. A large nationwide study, published in the journal Circulation on June 7, 2025, evaluated whether these digital prompts could improve treatment rates. The trial included over 23,000 patients with CKD and involved randomizing them to receive either an electronic nudge letter or usual care, along with their general practices being similarly assigned to receive informational letters or not.
The primary medications targeted were renin-angiotensin system inhibitors (RASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i), known for their benefits in CKD management. The results demonstrated that approximately 65% of patients, regardless of whether they received a nudge, filled prescriptions for these medications during the follow-up period. Similarly, no significant difference was observed in prescription rates among practices that received electronic informational letters versus those that did not. In essence, neither the patient-directed nor the provider-directed electronic interventions led to improved guideline-adherent medication use.
The researchers concluded that large-scale digital nudges, at least as implemented in this trial, do not enhance the adoption of recommended therapies in CKD management. This finding underscores the challenge of effecting behavioral change through electronic prompts and provides valuable insights for future efforts to improve medical guideline adherence. The study emphasizes the importance of exploring alternative strategies to increase the implementation of proven treatments for CKD.
For more details, see the full study in Circulation: DOI: 10.1161/CIRCULATIONAHA.125.075403. Source: https://medicalxpress.com/news/2025-06-electronic-nudge-letters-guideline-medical.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
AI-Driven Models Enhance Prediction of In-Hospital Mortality for ICU Cancer Patients
Machine learning models, including the CatBoost classifier, show high accuracy in predicting in-hospital mortality among ICU patients with lymphoma, offering valuable insights for personalized risk assessment.
New Research Identifies Enzyme Deficiency as Cause of Rare Skeletal Disorder
A groundbreaking study reveals that a deficiency in the enzyme TGDS leads to a rare skeletal disorder by disrupting glycosaminoglycan synthesis, offering new insights into diagnosis and treatment.
Major Challenges in Conducting Multinational Clinical Trials in Europe Uncovered
A new study uncovers significant ethical, regulatory, and logistical hurdles faced during European multinational clinical trials, highlighting the need for harmonized processes to accelerate research, especially during health crises.
Breakthrough in Human Genetics: Insights from the 1000 Genomes Project Reveal the Most Detailed Map of Human Genetic Variation to Date
Recent advancements in long-read sequencing technologies have enabled scientists to generate the most comprehensive map of human genetic variation to date, enhancing our understanding of genetics in health and disease.